Quarterly report pursuant to Section 13 or 15(d)

Other Income / (Expense) - Narrative (Details)

v3.23.3
Other Income / (Expense) - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Gain on sale of Investments $ 0 $ 11,682
ChemoCentryx    
Gain on sale of Investments   37,200
Eminence Biotechnology    
Gain on sale of Investments   $ 11,700
Exchanged traded investment grade bond funds    
Gain on sale of Investments $ 300